Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Health and Quality of Life Outcomes|December 21, 2012
Health-related quality of life (HRQL) for individuals with self-reported chronic physical and/or mental health conditions: panel survey of an adult sample in the United StatesMartha Bayliss, Regina Rendas-Baum, Michelle K White, et al.Lupus Science & Medicine|May 9, 2024
SF-36v2 and FACIT-Fatigue quality of life improvements with organ-specific SELENA-SLEDAI response and belimumab treatment in patients with systemic lupus erythematosusRegina Rendas-Baum, Wen-Hung Chen, Kerry Gairy, et al.Rheumatology (Oxford, England)|May 2, 2017
Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trialsRegina Rendas-Baum, Mark Kosinski, Amitabh Singh, et al.Health and Quality of Life Outcomes|August 2, 2014
Validation of the Headache Impact Test (HIT-6) in patients with chronic migraineRegina Rendas-Baum, Min Yang, Sepideh F Varon, et al.Journal of Patient-Reported Outcomes|January 22, 2024
Meaningful score changes for SF-36v2, FACIT-fatigue, and RASIQ in rheumatoid arthritisRegina Rendas-Baum, Xiaochen Lin, Mark Kosinski, et al.Arthritis Research & Therapy|February 18, 2011
Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitorsRegina Rendas-Baum, Gene V Wallenstein, Tamas Koncz, et al.Journal of Patient-Reported Outcomes|December 11, 2021
Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ)Brandon Becker, Marguerite Bracher, Deven Chauhan, et al.Health and Quality of Life Outcomes|March 24, 2016
Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studiesKelly M Grotzinger, Zobair M Younossi, Edoardo G Giannini, et al.Expert Review of Pharmacoeconomics & Outcomes Research|May 13, 2026
Estimating respiratory syncytial virus health utility values for older adults and their caregivers in the Japanese population: a time trade-off studyRegina Rendas-Baum, Jakob Bjorner, Victor Preckler, et al.Current Medical Research and Opinion|April 11, 2014
Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspectiveRegina Rendas-Baum, Martha Bayliss, Mark Kosinski, et al.Pageof 3